Table 1 - Three most important information needs among cancer patients

  Most important information needs      Type of cancer   Statistic
  Study    First   Second  Third    and time of information need   

Graydon et al. (1997, p.62)

Treatment

Disease

Investigative tests

Breast cancer
Time: treatment
 

Percentage mean

Galloway et al. (1997,  p. 1180)

Disease

Treatment

Investigative tests

Breast cancer
Time: treatment
 

Percentage mean

Harrison et al. (1999, p. 221)

Disease

Treatment

Investigative tests

Breast cancer 
Time: treatment and
post treatment
 

Percentage mean

Harrison-Woermke &
Graydon (1993, p. 453)    

Treatment

Physical

Diagnosis

Breast cancer
Time: treatment
 

Mean

Galloway and Graydon
 (1996, p. 116)
      
- pre-discharge group

Treatment and complications

Activities of living

Enhancing quality of life

Colon cancer
Time: during
hospital discharge
 
 

Percentage mean

Jenkins et al. (2001, p. 50)

Whether or not it is cancer (1)

What the chances of cure are (3)

What all the possible side effects of treatment are (2)

What all the possible treatments are (4)

 

Heterogeneous–
breast, gastro-intestinal,   hematological, lung, gynecological, urological, skin, CNS, head & neck, unknown primary, other
Time: not specified
 

Percentage

Meredith et al. (1996, p. 725)

Whether illness is cancer (1)

What the chances of cure are (3)

What are all possible side effects of treatment (2)

What is week by week progress (4)

 

Heterogeneous–
stomach, colon, lung, breast, cervix, ovary, bladder,
prostate, other
Time: not specified
 

Percentage

Stewart et al. (2000, p. 360)

Status and nature of cancer

Treatment concerns

Self-care and
empowerment issues

Ovarian cancer
Time: diagnosis, treatment, and  follow-up
 

Percentage

Iconomou et al. (2002, p. 318)

Aftermath of chemotherapy  (1)
How chemotherapy worked (3)
Duration of treatment (5)

Prognosis (2)

Diagnosis (4)

How to deal with
an emergency (6)

Heterogeneous–
breast, lung, colorectal, genitourinary, other
Time: treatment
 

Percentage

Davison et al. (1995, p. 1405)

Likelihood of cure (1)

Advance of disease (2)

Types of treatment available (3)
Effect of treatment on usual social activity (4)

Self-care needs (5)

Prostate cancer
Time: 0-6 months
post diagnosis
 

Thurstone scaling

Bilodeau & Degner (1996,  p. 695)

Stage of disease (1)

Likelihood of cure (2) 

Treatment options available (3)

Physical and emotional (4)

Breast cancer
Time: 0-6 months
post diagnosis
 

Thurstone scaling

Davison et al. (2002, p. 47)

Prognosis (1)

Stage of disease (2)

Treatment options (3)

Side effects (4)

Sexuality (5)

Prostate cancer
Time: after initial
treatment consultation
 

Thurstone scaling

Degner et al. (1997, p. 1491)  
      
- overall and newly 
          diagnosed groups

Chances of cure (1)

Stage of disease (2)

Treatment options (3)

Risks of a family member getting breast cancer (4)

Breast cancer
Time: newly
diagnosed and
treatment
 

Thurstone scaling

Luker et al. (1995, p. 138)
      
- newly diagnosed group  

Likelihood of cure (1)

Spread of disease (2)

Treatment options (3)

Family risk (4)

Breast cancer
Time: newly
diagnosed
 

Thurstone scaling

Luker et al. (1996, p. 490)
      
- newly diagnosed group      

Likelihood of cure (1)

Stage of disease (2)

Different types of treatment (3)

Family risk (4)

Breast cancer
Time: newly diagnosed
 

Thurstone scaling

      - follow-up group

Likelihood of cure (1)

Stage of disease (3)

Family risk (2)

Different types of treatment (4)

Breast cancer
Time: follow-up
at home
 

Thurstone scaling

Galloway et al. (1993, p. 118)
    
 - pre-discharge group

Treatment & complications (1)

Enhancing quality of life (2)

Skin care (3)

Lung cancer
Time: during
hospital discharge

Percentage mean

      - post-discharge group

Treatment & complications (1)

Enhancing quality of life (2)

Medication (3)

Lung cancer
Time: after
discharge at home
 

Percentage mean

Raupach & Hiller (2002, p. 293)
      
- follow-up group

Information about recognizing a recurrence (1)

Chances of cure (2)

Risk to family of
breast cancer (3)

Tamoxifen and other antiestrogen drugs (4)

Breast cancer
Time: post treatment
 

Percentages